1Price JL,Ko AI,Wade MJ,et al.Neuron number in the entorhinal cortex and CAI in preclinical Alzheimer disease[J].Arch Nueurol,2001,58(9):1395-1402.
2Bunce D,Fratiglioni L,Small BJ,et al.ApoE and cognitive decline inpreclinical Alzheimer disease and non-demented aging[J].Neurology,2004,63(5):816-821.
3Adak S,Illouz K,Gormar W,et al.Predicting the rate of cognitive decline in aging and early Alzhimer disease[J].Neurology,2004,63(1):108-114.
4Saxton J,Lopz OL,Ratcliff G,et al.Preclinical Alzheimer disease:neuropsychological test performance 1.5 to 8 years prior to onset[J].Neurology,2004,63 (12):2341-2347.
5Kawa CH,Corrada MM,Brookmeyer R,et al.Visual memory predicts Alzheimer's disease more than a decade before diagnosis[J].Neurology,2003,60(7):1089-1093.
6Schoonenboom NS,Pijnenburg YA,Mulder C,et al.Amyloid Beta (1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease[J].Neurology,2004,62(9):1580-1584.
7Quinn JF,Montine KS,Moore M,et al.Suppression of logitudinal increase in CSF F2-isoprostanes in Alzheimer's disease[J].J Alzheimer Dis,2004,6(1):93-97.
8Han X,Fagan AM,Cheng H,et al.Cerebrospinal Fluid sulfatide is decreased in subjects with incipient dementia[J].Ann Neurol,2003,54(1):115 -119.
9Phiel CJ,Wilson CA,Lee VMY,et al.GSK-3 alpha regulates production of Alzheimer's disease amloid-beta peptides[J].Nature,2003,423(6938):435-439.
10Hye A,Kerr F,Archer N,et al.Glycogenn synthase kinase-3 is increased in white cells early in Alzheimer's disease[J].Neurosci Lett,2005,373(1):1-4.
4Haasl RJ, Ahmadi MR, Meethal SV, et al. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele [ J ]. BMC Med Genet, 2008,9:37.
5Lane R, Feldman HH, Meyer J, et al. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease [ J ]. Pharmacogenet Genomics, 2008, 18 ( 4 ) : 289 -298.
6Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus : report of the international working group on mild cognitive impairment [ J ]. J Intern Med, 2004,256 ( 3 ) :240-246.
7Hollenbach E, Ackermann S, tion of an association between Hyman BT, et al. Confirmaa polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer' s disease [ J ]. Neurology, 1998, 50 (6) : 1905-1907.
8Wiebusch H, Poirier J, Sevigny P, et al. Further evidence for a synergistic association between APOE ε4 and BCHE-K in confirmed Alzheimer' s disease [ J ]. Hum Genet, 1999, 104(2) :158-163.
9Yoon IS, Chen E, Busse T, et al. Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway [ J ]. FASEB J, 2007,21 ( 11 ) :2742-2752.
10Diamant S, Podoly E, Friedler A, et al. Butyrylcholinesterase attenuates amyloid fibril formation in vitro[ J]. Proc Natl Acad Sci USA, 2006,103 ( 23 ) : 8628-8633.
